manufacturing prescription drugs, OTC drugs, health foods, active pharmaceutical ingredients and pharmaceutical intermediates.

We have established a strong presence in the pharmaceuticals segment and in the particular the field of digestive system medicine. Our barium sulfate X-ray contrast agents retain a leading share of the domestic market and we have also developed ethical drugs including Alroid G, a treatment for peptic ulcers made from algin acid, and Aethoxysclerol, a drug used in esophageal variceal sclerotherapy.
In addition, we have also developed a wide range of health foods and general medicines, such as cold remedy Kaigen, in order to respond to growing demand for self medication where people manage and monitor their health independently.
For more information about our active pharmaceutical ingredients and intermediates, please visit the corporate website of KATAYAMA SEIYAKUSYO CO., LTD.-for more information.

Sakai Chemical Group’s strengths

1. Our long-standing expertise and established credibility with healthcare professionals and pharmaceutical distributors means we can quickly respond to the true needs of healthcare today.
2. We are able to seamlessly integrate latent market needs with accumulated technology seeds.
3. We provide stable supplies of high quality pharmaceutical products that meet the rigorous demands of today’s healthcare.
4. Our nationwide network enables detailed support services, which ensures we provide a high level of customer satisfaction.

Main applications